Allergy and Airway |

What Have We Learned From the First European COPD Audit Study? Why We Need Audit Studies to Improve the Effectiveness of Health Care? FREE TO VIEW

Mehmet Polatli; Turkish Thoracic Society COPD Audit Turkey Study Group
Author and Funding Information

Adnan Menderes University, Aydin, Turkey

Chest. 2014;146(4_MeetingAbstracts):24A. doi:10.1378/chest.1989320
Text Size: A A A
Published online


SESSION TITLE: COPD Diagnosis and Evaluation Posters I

SESSION TYPE: Original Investigation Poster

PRESENTED ON: Wednesday, October 29, 2014 at 01:30 PM - 02:30 PM

PURPOSE: According to the report of Ministry of Health, COPD is ranked as third disease causing death at national level in Turkey and chronic airway diseases have a very big influence on the health expenses. Although effective guidelines are developed systematically to be used easily in busy practices and to ensure scientifically valid outcomes, guidelines alone cannot improve patient care. Physicians must be committed to guideline dissemination and implementation for patient outcomes to improve. Nevertheless, it is not exactly known whether COPD patients are adequately diagnosed, treated or followed in long term. There is growing evidence that the care of COPD patients may vary according to hospitals or countries and the accordance with the published guidelines usually seems to be inadequate. In this respect, Turkish Thoracic Society (TTS) decided to participate in European COPD Audit project which gave us the chance to face the problems related to the patients' admission to hospital and treatment of a COPD exacerbation.In this study, we wanted to point out positive and negative aspects in care of exacerbated COPD patients in Turkey.

METHODS: This study was based on the data of Turkey obtained from the results of the first European COPD Audit Report. The data collection was specified to patients experiencing an acute COPD exacerbation over a 60-day period who were hospitalized, following up for 90 days to assess outcomes. From Turkey, 22 hospitals (21 teaching/university hospital) participated to the study and 612 patients were evaluated for this study.

RESULTS: The overall mortality was 10.1% and more than half of patients were in GOLD stage III and IV. Dissimilarity in patient care resources observed among the hospitals, eg. only 22.7% of the hospitals had a pulmonary rehabilitation programme available for discharged patients. Only 49.3% of the patients had spirometry results before admission whose FEV1 results 36% predicted. The current smokers were 15.9 % of the patients.

CONCLUSIONS: The data ensured the importance of collecting data to make some recommendations for COPD care quality and raise the standard of care delivered to patients. Increasing spirometry and rehabilitation programme availability is important and the admission should be considered as an opportunity to quit smoking.

CLINICAL IMPLICATIONS: Increasing spirometry and rehabilitation programme availability is important and the admission should be considered as an opportunity to quit smoking.

DISCLOSURE: Mehmet Polatli: Fiduciary position (of any organization, association, society, etc, other than ACCP: Turkish Thoracic Society and British Thoracic Society sponsorship for attending to the ERS COPD Audit National Experts meeting The following authors have nothing to disclose: Turkish Thoracic Society COPD Audit Turkey Study Group

No Product/Research Disclosure Information




Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543